InsidersTradesSigma
Track the 武田薬品工業株式会社 stock price and the full directors' dealings record of the company, a listed issuer based in Japan. Shares trade on the JP market, under the authority of EDINET (Japan FSA). Market capitalisation: €9,018.5bn. The latest transaction was disclosed on 19 September 2025 (Holding update). Among the most active insiders: Sumitomo Mitsui Trust Asset Management Co.,Ltd.. Every trade is openly available.
Analysts rate 武田薬品工業株式会社 Buy (bullish), based on 16 analysts. Average price target: JP¥6,263.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Takeda Pharmaceutical Company Limited es una empresa farmacéutica japonesa enfocada en la investigación, desarrollo y comercialización de medicamentos. Cotiza en la Bolsa de Valores de Tokio bajo el símbolo XTKS.